News & Trends - Medical Technology

TGA releases new regulations for software-based medical devices

Health Industry Hub | February 5, 2020 |
[Total: 1    Average: 5/5]

The Therapeutics Good Administration (TGA) released guidance to help medical software manufacturers understand the criteria for the qualification of software under the the Therapeutic Goods (Medical Devices) Regulations 2002 (the Regulations), amended on 12 December 2019.

Software as a medical device (SaMD)

Medical device software is software that is intended to be used, alone or in combination, for a purpose as specified in the definition of a “medical device” in the MDR or IVDR, regardless of whether the software is independent or driving or influencing the use of a device.

What’s changing

The Regulations have been amended in relation to software-based medical devices including programmed and programmable hardware (referred to collectively as ‘programmed or programmable medical device, or software that is a medical device’):

  • New classification rules have been introduced to classify devices of this kind according to their potential to cause harm through the provision of incorrect information.
    1. The rules are largely aligned with the software rules in the EU MDR 2017
    2. In some cases, a device will be a lower classification (where a relevant healthcare professional is involved);
    3. Devices that provide direct diagnosis or monitoring will be the same class in most cases.
    4. Devices intended to provide therapy via the provision of information (e.g., a medical device intended to provide cognitive behavioural therapy) will potentially be a higher class in some cases.
    5. The new classification rules will not apply to in vitro diagnostic (IVD) medical devices.

  • Essential principle 12.1 has been amended to clarify the expectations around these types of devices, including with regards to cyber security; the management of data and information; and requirements relating to development, production, and maintenance.
  • Essential Principle 13.2(3) has been amended to allow information, where applicable, to be provided electronically rather than on a leaflet for medical devices that are software.
  • A new requirement has been introduced, as Essential Principle 13B, for identification of current version and build number to be made accessible by, and identifiable to, users of medical devices that are, or that incorporate, software. 

Further guidance will be provided in early 2020.

Important dates

The new software regulations will commence on 25 August 2020 for new applications for inclusion.

Transitional arrangements for medical devices that are included in the ARTG on this date will apply.

You may also like Medtronic’s new software to enhance efficiency of targeted drug delivery for clinicians

Register FREE to receive the latest news, innovations and insights from Health Industry Hub; the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.


About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile

Marketing & Strategy

Marketing Pharma Biotech Healthcare - PRIME Awards 2020 finalists announced

PRIME Awards 2020 finalists announced

Health Industry Hub | August 7, 2020 |

The finalists for PRIME Awards 2020 have been named, with winners to be announced via a virtual ceremony on Thursday […]

More


News & Trends - Pharmaceuticals

Pharma News - New Ventolin inhalers with dose counter reimbursed on the PBS

New Ventolin inhalers with dose counter reimbursed on the PBS

Health Industry Hub | August 7, 2020 |

Pharma News: GSK Australia is pleased to announce that a dose counter has been added to VENTOLIN (salbutamol sulfate) metered […]

More


News & Trends - Medical Technology

MedTech News - Siemens Healthineers to acquire Varian in $16.4bn deal

Siemens Healthineers to acquire Varian in $16.4bn deal

Health Industry Hub | August 5, 2020 |

MedTech News: Siemens Healthineers shall acquire Varian Medical Systems for approximately USD$16.4 billion. Since 2012, Siemens Healthineers and Varian have […]

More


News & Trends - Pharmaceuticals

Pharma News - New anti-cancer drug for prostate cancer

New anti-cancer drug for prostate cancer

Health Industry Hub | August 5, 2020 |

Pharma News: A new anti-cancer drug for prostate cancer overcomes the twin problems plaguing researchers for decades. It halts metastasis […]

More